Nursing Considerations for Patients Treated with Targeted Therapies
作者： Kelly E. Goodwin , Marianne Davies
DOI: 10.1007/978-3-030-16550-5_9
关键词:
摘要: Delivery of personalized, effective therapy to patients with metastatic lung cancer an identified driver mutation can be challenging and rewarding. Nurses make significant impacts in the management these complex through access therapy, education, telephone triage, interventions improve adherence persistence, care coordination/navigation. A multidisciplinary team approach may patient quality life survival.
springer.com
sci-hub.st 参考文章(61)
Peggy Burhenn, Josephine Smudde, Using tools and technology to promote education and adherence to oral agents for cancer. Clinical Journal of Oncology Nursing. ,vol. 19, pp. 53- 59 ,(2015) , 10.1188/15.S1.CJON.53-59
Chien-Chou Pan, Pei-Tseng Kung, Yueh-Hsin Wang, Yu-Chia Chang, Shih-Ting Wang, Wen-Chen Tsai, None, Effects of Multidisciplinary Team Care on the Survival of Patients with Different Stages of Non-Small Cell Lung Cancer: A National Cohort Study PLOS ONE. ,vol. 10, pp. e0126547- ,(2015) , 10.1371/JOURNAL.PONE.0126547
Marie Barillet, Virginie Prevost, Florence Joly, Bénédicte Clarisse, Oral antineoplastic agents: how do we care about adherence? British Journal of Clinical Pharmacology. ,vol. 80, pp. 1289- 1302 ,(2015) , 10.1111/BCP.12734
Pascal Wolter, Patrick Schöffski, Veerle Foulon, Patient adherence to oral anticancer drugs: an emerging issue in modern oncology Acta Clinica Belgica. ,vol. 66, pp. 85- 96 ,(2014) , 10.2143/ACB.66.2.2062525
Brandi Anders, Alexandra Shillingburg, Michael Newton, Oral Antineoplastic Agents: Assessing the Delay in Care. Chemotherapy Research and Practice. ,vol. 2015, pp. 512016- 512016 ,(2015) , 10.1155/2015/512016
A. Goren, M. DiBonaventura, R. Wagner, Adherence And Its Association With Health Outcomes Among Patients Currently Treated For Leukemia, Melanoma, Or Non-Small Cell Lung Cancer (Nsclc) Value in Health. ,vol. 16, ,(2013) , 10.1016/J.JVAL.2013.03.709
Barbara Melosky, Vera Hirsh, Management of Common Toxicities in Metastatic NSCLC Related to Anti-Lung Cancer Therapies with EGFR–TKIs Frontiers in Oncology. ,vol. 4, pp. 238- 238 ,(2014) , 10.3389/FONC.2014.00238
P.M. Ellis, The importance of multidisciplinary team management of patients with non-small-cell lung cancer Current Oncology. ,vol. 19, pp. 7- 15 ,(2012) , 10.3747/CO.19.1069
Justin F. Gainor, Sai-Hong Ignatius Ou, Jennifer Logan, Lawrence F. Borges, Alice T. Shaw, The central nervous system as a sanctuary site in ALK-positive non-small-cell lung cancer. Journal of Thoracic Oncology. ,vol. 8, pp. 1570- 1573 ,(2013) , 10.1097/JTO.0000000000000029
Antonio M. P. Omuro, Mark G. Kris, Vincent A. Miller, Enrico Franceschi, Neelam Shah, Daniel T. Milton, Lauren E. Abrey, High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinib. Cancer. ,vol. 103, pp. 2344- 2348 ,(2005) , 10.1002/CNCR.21033